Para citar este trabalho use um dos padrões abaixo:
Ulcerative colitis (UC) is a chronic inflammatory bowel disease marked by colonic mucosal inflammation, diarrhea, abdominal pain, and weight loss, with current therapies often limited by adverse effects. Natural polysaccharides demonstrate significant therapeutic potential against ulcerative colitis. Since Eryngium foetidum (chicória-brava) is traditionally used for gastrointestinal disorders, this study investigates its polysaccharide fraction (EF), a mixture of type II arabinogalactan (AG-II), homogalacturonan (HG) and type I rhamnogalacturonan (RG-I) in a colitis model.
Female Swiss mice (~30g, n=8 per group) were randomly assigned to control, DSS + vehicle (10 mL/kg), or DSS+EF (1, 10, or 100 mg/kg) groups and treated orally once daily for 7 days. UC was induced by 5% DSS in drinking water for 5 days, followed by 2 days of water. Mice were monitored daily for body weight changes, Disease Activity Index (DAI: weight loss, stool consistency, fecal blood) and occult blood (Meyer-Johannessen method). Mechanical visceral hypersensitivity was evaluated using von Frey filaments, and welfare was assessed via nest-building behavior. On day 8, animals were euthanized to assess colon length, tissue MPO activity, GSH levels, acidic and neutral mucins (Alcian blue/PAS histochemistry), and MUC-2 and PCNA expressions (immunohistochemistry). All experimental procedures were approved by the Animal Ethics Committee of the Federal University of Paraná (CEUA/BIO–UFPR, approval number 1476).
EF at all tested doses significantly improved DAI scores in 45, 48 and 52% when compared to DSS group (5.2 ± 0.62). At 100 mg/kg, EF decreased fecal occult blood, reduced colonic MPO (49%) and IL-1β (91%), preserved acidic (40%) and neutral mucins (31%), and increased MUC-2 (150%) and PCNA (186%) immunoreactivity. Nest-building scores were also recovered by 84%. In sharp contrast, EF failed to prevent weight loss, colon shortening, GSH depletion, and mechanical visceral allodynia.
Collectively, these findings demonstrate that EF exerts marked anti-inflammatory and barrier-protective effects in acute colitis, primarily by preserving mucosal mucins and attenuating inflammation, thereby supporting the scientific rationale for its traditional use in gastrointestinal inflammatory disorders. However, although EF targets local colonic inflammation and preserves mucin, its therapeutic efficacy is insufficient to prevent systemic disease progression or structural damage in DSS-induced colitis.
In conclusion, this study demonstrates the therapeutic potential of water-soluble polysaccharides from Eryngium foetidum, highlighting the role of their pectic structural domains (AG-II, HG, and RG-I) as promising anti-inflammatory and mucosal-protective agents against acute colitis in mice.
This work was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) - Finance Code 001 and Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq (Proc. Proc. 308816/2023-4).
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo